Loading...
FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination
BACKGROUND: FTY720 (fingolimod) is the first oral drug approved by the Food and Drug Administration for treatment of patients with the relapsing-remitting form of the human demyelinating disease multiple sclerosis. Evidence suggests that the therapeutic benefit of FTY720 occurs by preventing the egr...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4148542/ https://ncbi.nlm.nih.gov/pubmed/25138356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-014-0138-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|